Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes

Acta Pharmacologica Sinica

Volumn 28, Issue 8, 2007, Pages 1129-1135

  Yue, Yun ^a   Hu, Ling ^b   Tian, Qin Jie ^b   Jiang, Jing Mei ^a   Dong, Yi Long ^a   Jin, Zheng Yu ^b   Cheng, Yu Hang ^c   Hong, Xia ^b   Ge, Qin Sheng ^b   Zuo, Ping Ping ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; apoE; Hormone replacement therapy; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN E; CREATININE; INOSITOL; N ACETYLASPARTIC ACID; SEX HORMONE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; BRAIN SIZE; CHEMICAL ANALYSIS; CINGULATE GYRUS; COGNITION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; EDUCATION; EVALUATION; FEMALE; GENE; GENOTYPE; HETEROZYGOTE; HIPPOCAMPUS; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PROTON NUCLEAR MAGNETIC RESONANCE; RISK REDUCTION; STATISTICAL SIGNIFICANCE; THERAPY EFFECT;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASPARTIC ACID; COGNITION; CREATININE; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; GENOTYPE; HIPPOCAMPUS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTMENOPAUSE; RETROSPECTIVE STUDIES;

EID: 34547558283     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00618.x     Document Type: Article

References (30)

1. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993 90 : 1977 81.
2. Martins RN, Clarnette R, Fisher C, Bore GA, Brooks WS, Montgomery P, et al. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport 1995 6 : 1513 6.
3. Farrer LA, Cupples LA, Van Duijn CM, Connor-Lacke L, Kiely DK, Growdon JH. Rate of progression of Alzheimer's disease is associated with genetic risk. Arch Neurol 1995 52 : 918 23.
4. Payami H, Zareparsi S, Montee KR, Sexton GJ, Kaye JA, Bird TD, et al. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet 1996 58 : 803 11.
5. Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997 60 : 439 46.
6. Bradbury J. Low brain oestrogen linked to Alzheimer's disease risk. Lancet Neurol 2006 5 : 116 7.
7. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 2005 102 : 19198 203.
8. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996 348 : 429 32.
9. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry 1999 46 : 182 8.
10. Steffens DC, Norton MC, Plassman BL, Tschanz JT, Wyse BW, Welsh-Bohmer KA, et al. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc 1999 47 : 1171 5.
11. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lan DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA 2004 291 : 2947 58.
12. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003 289 : 2651 62.
13. Craig MC, Maki PM, Murphy DG. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol 2005 4 : 190 4.
14. Burkhardt MS, Foster JK, Laws SM, Baker LD, Craft S, Gandy SE, et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOEe4. J Alzheimers Dis 2004 6 : 221 8.
15. Nie M, Sun ML, Ge QS. Effects of long-term and low-dose hormone replacement therapy on bone mineral density in postmenopausal women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006 28 : 421 4. Chinese.
16. Song YH, Shen Y, Sun ML, Ge QS. Effect of low-dose long-term hormone replacement therapy on serum lipids in postmenopausal women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2006 15 : 157 60. Chinese.
17. Sherwin BB. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us? Ann N Y Acad Sci 2005 1052 : 3 10.
18. Maki PM. Hormone therapy and risk for dementia: where do we go from here? Gynecol Endocrinol 2004 19 : 354 9.
19. Harman SM, Naftolin F, Brinton EA, Judelson DR. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Ann N Y Acad Sci 2005 1052 : 43 56.
20. Henderson VW. Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother 2004 5 : 389 406.
21. Ge QS, Tian QJ, Hung TS, Frederick N. Development of low- dose reproductive hormone therapies in China. Gynecological Endocrinol 2006 22 : 1 10.
22. Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 2006 63 : 1434 9.
23. van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YA, Barkhof F, et al. Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006 77 : 439 42.
24. Gold JJ, Hopkins RO, Squire LR. Single-item memory, associative memory, and the human hippocampus. Learn Mem 2006 77 : 439 42.
25. Nie M, Sun ML, Song AL, Ge QS. The effects of long-tem and low-dose of hormone replacement therapy on blood pressure and blood vessel bioactive factors in postmenopausal women. J Reprod Med 2005 14 : 321 4.
26. Kantarci K, Jack CR Jr., Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H-MRS study. Neurology 2000 55 : 210 7.
27. Frey R, Metzler D, Fischer P, Heiden A, Scharfetter J, Moser E, et al. Myo-inositol in depressive and healthy subjects determined by frontal 1H magnetic resonance spectroscopy at 1.5 tesla. J Psychiatr Res 1998 32 : 411 20.
28. Jones RN, Gallo JJ. Education bias in the mini-mental state examination. J Int Psychogeriatr 2001 13 : 299 310.
29. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997 42 : 85 94.
30. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 2001 286 : 2120 7.